Latest News for: cmv

Edit

Safer Roads - Safer Winter: State leaders highlight new I-70 CMV left-lane restrictions and winter travel preparedness (Colorado Department of Transportation)

Public Technologies 04 Dec 2025
State leaders highlight new I-70 CMV left-lane restrictions and winter travel preparedness Dec. 3, 2025 - Denver Metro/Central Colorado https.//www.codot.gov/news/2025/december/i70-cmv-lane-restrictions https.//www.codot.gov/@@site-logo/siteLogo.png.
Edit

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

Nasdaq Globe Newswire 20 Nov 2025
EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in ...
Edit

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1 (Form 6-K) (Evaxion A/S)

Public Technologies 20 Nov 2025
Despite decades of research, no CMV vaccine has been approved to date, underscoring the importance of these new discoveries ... With our AI-Immunology™ platform, we have uncovered novel antigens that are entirely new to the CMV vaccine research field.
Edit

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1 (Evaxion A/S)

Public Technologies 20 Nov 2025
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1. Evaxion's AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models.
Edit

ID Week (CMV mRNA-1647 immunogenicity following 2 or 3 doses) (Moderna Inc)

Public Technologies 23 Oct 2025
CMV-Specific CD4+ and CD8+ T-Cell Responses to 2- and 3-Dose mRNA-1647 Schedules Through 12 Months Among (A) CMV-Seronegative and ... CMV infection3,4 ... Schedules Through 12 Months Among CMV-Seronegative (A) and CMV-Seropositive Participants (B).
Edit

Reflecting on Moderna’s Phase 3 CMV Vaccine Readout (Moderna Inc)

Public Technologies 22 Oct 2025
) Today, we announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, our investigational cytomegalovirus (CMV) vaccine.
Edit

IR Insights: An Update on Moderna’s CMV Program (Moderna Inc)

Public Technologies 22 Oct 2025
) Earlier today, Moderna announced the Phase 3 results for its investigational cytomegalovirus vaccine. [...] ... Disclaimer ... (noodl.
Edit

Nebraska Shares CMV Crash Expertise With 11 States

TT News 22 Oct 2025
“Teamwork across state lines is important to keep America’s roadways safe,” Nebraska State Police Capt. Martin Denton, of carrier enforcement, said Oct. 14 ... .
Edit

ID Week (CMV mRNA-1647 in patients who have undergone hematopoietic cell transplant) (Moderna Inc)

Public Technologies 20 Oct 2025
Cytomegalovirus (CMV) is associated with substantial morbidity and mortality in immunocompromised patients, including allogeneic hematopoietic cell transplantation (HCT) recipients ... mRNA-1647- An Investigational CMV Vaccine ... CMV PCR monitoring.
Edit

Cytomegalovirus (CMV) Infection Pipeline 2025: Innovative Clinical Developments by 15+ Global Leaders – DelveInsight | ...

GetNews 17 Oct 2025
"Cytomegalovirus (CMV) Infection Pipeline 2025" ... DelveInsight reports that over 15 pharmaceutical and biotech companies are actively advancing more than 20 therapeutic candidates targeting CMV infection ... Cytomegalovirus (CMV) Infection Overview..
×